Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Aug;106(4):797–801. doi: 10.1111/j.1476-5381.1992.tb14415.x

Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

S M Yu 1, S Y Hsu 1, F N Ko 1, C C Chen 1, Y L Huang 1, T F Huang 1, C M Teng 1
PMCID: PMC1907686  PMID: 1356567

Abstract

1. The haemodynamic effects of dicentrine, an aporphine derivative isolated from the plant Lindera megaphylla, were investigated and compared with prazosin in rats. 2. In anaesthetized normotensive Wistar-Kyoto (WKY) rats, i.v. administration of dicentrine (0.1, 0.5, 1.0 mg kg-1) and prazosin (0.01, 0.05, 0.1 mg kg-1) induced a dose-related reduction of mean arterial pressure (MAP) which reached a maximal effect 5-10 min after injection and persisted for 2 h. 3. In anaesthetized WKY rats, a higher dose of dicentrine (1.0 mg kg-1, i.v.) did not cause any significant changes in heart rate (HR), cardiac output (CO) and stroke volume (SV) but markedly increased tail blood flow. In contrast, a higher dose of prazosin (0.1 mg kg-1, i.v.) produced a decrease in HR which paralleled the time course of the hypotensive response. 4. The hypotensive activity of dicentrine was completely abolished by alpha-adrenoceptor blockade. Both dicentrine and prazosin significantly attenuated pressor responses to noradrenaline but failed, even at maximal hypotensive doses, to impair the pressor effects of angiotensin II or vasopressin. These observations suggest that dicentrine appears to exert its hypotensive action through alpha 1-adrenoceptor blockade. 5. In conscious normotensive and spontaneously hypertensive (SH) rats, dicentrine (0.5-2.0 mg kg-1, i.v.) and prazosin (0.05-0.2 mg kg-1, i.v.) also evoked dose-related decreases in MAP which were of greater magnitude in SH rats. Oral administration of dicentrine (5 and 8 mg kg-1) to conscious SH rats caused a hypotensive effect which persisted for over 15 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
797

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Borg K. O., Carlsson E., EK L., Johnson G., Malmfors T., Regårdh C. G. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):7–23. doi: 10.1111/j.1600-0773.1975.tb03318.x. [DOI] [PubMed] [Google Scholar]
  2. Cambridge D., Davey M. J., Massingham R. The pharmacology of antihypertensive drugs with special reference to vasodilators, alpha-adrenergic blocking agents and prazosin. Med J Aust. 1977 Aug 20;2(1 Suppl):2–6. doi: 10.5694/j.1326-5377.1977.tb107750.x. [DOI] [PubMed] [Google Scholar]
  3. Cassis L. A., Stitzel R. E., Head R. J. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp Ther. 1985 Sep;234(3):792–803. [PubMed] [Google Scholar]
  4. Cavero I., Roach A. G. The pharmacology of prazosin, a novel antihypertensive agent. Life Sci. 1980 Oct 27;27(17):1525–1540. doi: 10.1016/0024-3205(80)90561-5. [DOI] [PubMed] [Google Scholar]
  5. Chen C. C., Huang Y. L., Ou J. C., Su M. J., Yu S. M., Teng C. M. Bioactive principles from the roots of Lindera megaphylla. Planta Med. 1991 Oct;57(5):406–408. doi: 10.1055/s-2006-960135. [DOI] [PubMed] [Google Scholar]
  6. Constantine J. W., Weeks R. A., McShane W. K. Prazosin and presynaptic alpha-receptors in the cardioaccelerator nerve of the dog. Eur J Pharmacol. 1978 Jul 1;50(1):51–60. doi: 10.1016/0014-2999(78)90252-2. [DOI] [PubMed] [Google Scholar]
  7. Donohue S. J., Stitzel R. E., Head R. J. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther. 1988 Apr;245(1):24–31. [PubMed] [Google Scholar]
  8. FREIS E. D., MacKAY J. C., OLIVER W. F. The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man. Circulation. 1951 Feb;3(2):254–259. doi: 10.1161/01.cir.3.2.254. [DOI] [PubMed] [Google Scholar]
  9. Graham R. M., Oates H. F., Stoker L. M., Stokes G. S. Alpha blocking action of the antihypertensive agent, prazosin. J Pharmacol Exp Ther. 1977 Jun;201(3):747–752. [PubMed] [Google Scholar]
  10. Hardey D. W., Lokhandwala M. F. Influence of prazosin on cardiac reflex function. Eur J Pharmacol. 1979 Aug 1;57(2-3):251–254. doi: 10.1016/0014-2999(79)90373-x. [DOI] [PubMed] [Google Scholar]
  11. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  12. Head R. J., Cassis L. A., Robinson R. L., Westfall D. P., Stitzel R. E. Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels. 1985;22(4):196–204. doi: 10.1159/000158601. [DOI] [PubMed] [Google Scholar]
  13. Koch-Weser J., Graham R. M., Pettinger W. A. Drug therapy. Prazosin. N Engl J Med. 1979 Feb 1;300(5):232–236. doi: 10.1056/NEJM197902013000505. [DOI] [PubMed] [Google Scholar]
  14. Massingham R., Hayden M. L. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs. Eur J Pharmacol. 1975 Jan;30(1):121–124. doi: 10.1016/0014-2999(75)90213-7. [DOI] [PubMed] [Google Scholar]
  15. Minneman K. P. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev. 1988 Jun;40(2):87–119. [PubMed] [Google Scholar]
  16. Persson B., Yao T., Thorén P. Correlation between decreased heart rate and central inhibition of sympathetic discharge after prazosin administration in the spontaneously hypertensive rat. Clin Exp Hypertens. 1981;3(2):245–255. doi: 10.3109/10641968109033663. [DOI] [PubMed] [Google Scholar]
  17. Stanaszek W. F., Kellerman D., Brogden R. N., Romankiewicz J. A. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs. 1983 Apr;25(4):339–384. doi: 10.2165/00003495-198325040-00002. [DOI] [PubMed] [Google Scholar]
  18. Teng C. M., Yu S. M., Ko F. N., Chen C. C., Huang Y. L., Huang T. F. Dicentrine, a natural vascular alpha 1-adrenoceptor antagonist, isolated from Lindera megaphylla. Br J Pharmacol. 1991 Nov;104(3):651–656. doi: 10.1111/j.1476-5381.1991.tb12484.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Titmarsh S., Monk J. P. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. Drugs. 1987 May;33(5):461–477. doi: 10.2165/00003495-198733050-00003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES